Table 1. Clinical traits in PC patients with non-diabetes and diabetes.
| Non-diabetes PC(n = 99) | Diabetes PC(n = 37) | |||||
|---|---|---|---|---|---|---|
| Factors | Death/patients | Log-rank | Multivariate Cox P | Death/patients | Log-rank | Multivariate Cox P |
| Age | 0.051 | 0.496 | 0.959 | 0.446 | ||
| <=64 | 22/52 | 7/16 | ||||
| >64 | 31/47 | 8/21 | ||||
| Gender | 0.402 | 0.172 | 0.001* | 0.340 | ||
| Female | 27/50 | 7/12 | ||||
| Male | 26/49 | 8/25 | ||||
| Tumor Status | 9.3e−06* | 0.0004* | 0.005* | 0.513 | ||
| With Tumor | 42/57 | 10/17 | ||||
| Tumor Free | 6/35 | 2/15 | ||||
| Unknown | 7/7 | 3/5 | ||||
| Alcohol history | 0.537 | 0.144 | 0.599 | 0.638 | ||
| Yes | 40/68 | 10/27 | ||||
| No | 12/39 | 5/10 | ||||
| Unknown | 1/2 | – | ||||
| History of chronic pancreatitis | 0.597 | 0.998 | 0.273 | 0.998 | ||
| Yes | 4/8 | 3/4 | ||||
| No | 48/86 | 10/31 | ||||
| Unknown | 1/5 | 2/2 | ||||
| Number of lymph nodes positive by he | 0.003* | 0.396 | 0.480 | 0.533 | ||
| <3 | 22/52 | 7/20 | ||||
| >=3 | 30/45 | 8/16 | ||||
| Maximum tumor dimension | 0.394 | 0.216 | 0.147 | 0.279 | ||
| >3.5 | 27/44 | 9/16 | ||||
| <=3.5 | 26/51 | 6/20 | ||||
| Neoplasm histologic grade | 0.039* | 0.004* | ||||
| G1 | 4/16 | – | 2/7 | – | ||
| G2 | 31/52 | 0.606 | 6/20 | 0.998 | ||
| G3 | 17/29 | 0.202 | 7/10 | 0.308 | ||
| G4 | 1/2 | 0.757 | – | – | ||
| TNM stage | 0.100 | 0.431 | ||||
| Stage I | 0/1 | – | 0/1 | – | ||
| Stage IA | 1/3 | 0.997 | 0/1 | 0.998 | ||
| Stage IB | 3/10 | 0.998 | 0/2 | 0.998 | ||
| Stage IIA | 5/13 | 0.998 | 3/7 | 0.998 | ||
| Stage IIB | 43/70 | 0.998 | 11/24 | 0.998 | ||
| Stage III | 1/2 | – | 0/1 | – | ||
| Stage IV | – | – | 1/1 | – | ||
Notes.
*
p < 0.05, statistically significant.